GlassScriptPhysician profile
Graydon Ramos Carr
NPI 1255852620
$2,204.58
in general payments reported to CMS, 2019-2025
9 companies · $252 in 2025
The $252 reported for 2025 was more than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.20 · 2020: $18.62 · 2021: $121 · 2022: $572 · 2023: $208 · 2024: $1,021 · 2025: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,128 · Travel and Lodging: $222 · Gift: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,128.47 |
| Travel and Lodging | $222.29 |
| Gift | $130.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $1,483.20 | 2022-2025 | Invisalign, Touch Up |
| Henry Schein, INC. | $218.35 | 2023-2025 | |
| 3m Company | $169.71 | 2020-2022 | |
| Envista Holdings Corporation | $108.60 | 2024-2025 | Spark, Mara |
| Solventum Corporation | $80.74 | 2024-2025 | 3m, Clarity Aligners |
| American Orthodontics Corporation | $66.24 | 2024-2025 | Master Series, Empower-Metal, Radiance |
| World Class Technology Corporation | $37.50 | 2025 | Pitts21, Pitts21 Pro |
| USA Angelalign Technology Corp | $28.04 | 2025 | |
| Voco America INC. | $12.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Graydon Carr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.